Results 201 to 210 of about 7,263 (276)

Postoperative nausea and vomiting: translating pathophysiological mechanisms into clinical management. [PDF]

Perioper Med (Lond)
Zhao X, Liao W, Chen C, Zheng Y, Li L, Chang Q, Qiu L, Shen J.   +7 more
europepmc   +1 more source

Fosnetupitant/Palonosetron Hydrochloride [PDF]

, 2020
openaire   +1 more source

Exploring antiemetic strategies in hematologic malignancies: a comprehensive literature review and evaluation of antiemetic efficacy in patients receiving high-dose chemotherapy prior to hematopoietic stem cell transplantation. [PDF]

Support Care Cancer
Jordan K, Jordan B, Burgt JV, Jahn F.
europepmc   +1 more source

Effectiveness of the combination of netupitant and palonosetron in the prevention of nausea and vomiting during anthracycline-containing chemotherapy in patients with breast cancer

Katerina Grechukhina, E. M. Kolyago, M. V. Kalugin, Lyudmila Zhukova   +3 more
openalex   +2 more sources

Efficacy of intensive antiemetic therapy including olanzapine in multiple myeloma patients treated with high-dose melphalan with autologous stem cell transplantation. [PDF]

Support Care Cancer
Kato J, Uchida M, Ishikawa M, Tatsuta S, Yoshimi T, Ishida K, Hosoya O, Tsukada N, Ishida T, Shiko Y, Kawasaki Y, Yamazaki S, Ishii I.   +12 more
europepmc   +1 more source

Efficacy of single low-dose dexamethasone with NEPA for the 168 h prevention of highly or moderately emetogenic chemotherapy. [PDF]

Front Pharmacol
He Y, Lou F, Huang X, Zhang Y, Lin Q, Tan W, Chen Q, Ren X, Shi H, Xiao L.   +9 more
europepmc   +1 more source

Clinical Study on Palonosetron Combined with GDP Regimen in Treatment of Elderly Patients with Relapsed Non-Hodgkin's Lymphoma

, 2013
YE Wei-de
openalex   +1 more source

Evaluation of Emetogenic Mechanisms of Antineoplastic Drugs on 5-HT3A Receptor Using a Structure-Based Computational Approach. [PDF]

J Clin Pract Res
Çalışkaner ZO.
europepmc   +1 more source

Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials. [PDF]

BMC Cancer
Kojima S, Inui N, Suzuki T, Tanaka K, Karayama M, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nishimoto K, Matsuura S, Hashimoto D, Matsui T, Asada K, Suda T.   +17 more
europepmc   +1 more source

Formulation development and In vivo evaluation of mouth dissolving films containing Palonosetron HCl

, 2016
Jyothi Sri S, Darna Biksha Pathi
openalex   +1 more source